Pei Kan
17Patents
3h-index
27Co-inventors
60Inventor score
Filing activity: Jul 2, 1993 → Mar 18, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7179867B2 | Thermosensitive biodegradable copolymer | Chemistry; Metallurgy | 12 | Expired |
| US5407579A | Hemoglobin purification | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7588778B2 | Delivery carrier for targeting to cells expressed with somatostatin receptors | Human Necessities | 3 | Expired |
| US9700511B2 | Controlled drug release liposome composition | Emerging Cross-Sectional Technologies | 2 | Active |
| US8124128B2 | Amphiphilic block copolymers and nano particles comprising the same | Emerging Cross-Sectional Technologies | 2 | Active |
| US8940333B2 | Amphiphilic block copolymers and nanoparticles comprising the same | Emerging Cross-Sectional Technologies | 2 | Active |
| US10391056B2 | Pharmaceutical compositions of hydrophobic camptothecin derivatives | Human Necessities | 1 | Active |
| US10220095B2 | Controlled drug release liposome compositions and methods thereof | Human Necessities | 1 | Active |
| US10980798B2 | Pharmaceutical compositions of hydrophobic camptothecin derivatives | Human Necessities | 0 | Active |
| US11229616B2 | Pharmaceutical composition for controlled release of treprostinil | Human Necessities | 0 | Active |
| US7485320B2 | Liposome for incorporating large amounts of hydrophobic substances | Human Necessities | 0 | Expired |
| US11964050B2 | Liposome compositions comprising weak acid drugs and uses thereof | Human Necessities | 0 | Active |
| US11833125B2 | Pharmaceutical composition for controlled release of treprostinil | Human Necessities | 0 | Active |
| US12064406B2 | Pharmaceutical composition of a weak acid drug and methods of administration | Human Necessities | 0 | Active |
| US12220483B2 | Liposome compositions comprising weak acid drugs and uses thereof | Human Necessities | 0 | Active |
| US11147881B2 | Controlled drug release liposome compositions and methods thereof | Human Necessities | 0 | Active |
| US8420119B2 | Drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.